Compare Travere Therapeutics Inc. Common Stock (TVTX) vs Western Digital Corp (WDC) Price & Performance

Travere Therapeutics (TVTX) trades at $51.80, down 0.42% on the day, with a neutral technical signal. The company reported strong revenue growth but persistent net losses, with a 2025 net income margin of -7.35%. Recent news includes new data presentations for its key drug FILSPARI and a CEO transition. Analyst consensus is strongly bullish with an 83.33% buy rating and a $70.60 price target, suggesting significant upside from the current price.

The outlook for TVTX hinges on the commercial success of FILSPARI, which shows promising sales growth, but profitability remains a challenge. Key risks include execution of the CEO transition, competitive pressures in nephrology treatments, and the company's ability to achieve sustained profitability. The high valuation multiples relative to negative earnings present a risk-reward balance for investors.

Western Digital (WDC) trades at $380.71, down 1.61% amid recent volatility driven by news of Toshiba's planned HDD capacity expansion. The stock shows strong fundamentals with a P/E of 13.53 and net income margin of 71.97% for 2025, supported by three consecutive quarterly earnings beats. Technical indicators are mixed, with a bearish moving average signal but oversold RSI levels suggesting potential near-term support.

Outlook remains positive long-term given WDC's leadership in AI storage and robust analyst consensus (72% buy ratings, $643 price target), but near-term risks include increased competition and pricing pressure. The stock's current valuation presents an opportunity if execution continues, though investors should monitor competitive dynamics and margin trends closely.